Biologics

Top Story

BONESUPPORT announces IPO on Nasdaq Stockholm

June 18, 2017

BONESUPPORT announced its board of directors has applied for shares of the company to be admitted into trading on Nasdaq Stockholm’s main market, according to a company press release.

BONESUPPORT develops injectable, bioceramic bone graft substitutes with the capability of eluting drugs into the bone void. Cerament G and other products are part of BONESUPPORT’s Cerament technology platform.

Point/Counter

What is the best current delivery method to ensure mesenchymal stem cells get to the intended target in the shoulder?

Orthopedics Today, June 2017
The best delivery method into the shoulder for mesenchymal stem cells (MSCs), PRP or other substances is based on the injection technique. The injection approach and…
Cover Story

Controversy, cost may not dim potential of stem cells in the shoulder

Orthopedics Today, June 2017
It is widely known and reported in the literature that shoulder injuries, including rotator cuff tears, tend to heal slowly and the management of glenoid labral tears…

Bioventus announces expansion of surgical orthobiologics portfolio offering with Premier

June 10, 2017
Bioventus announced its full surgical orthobiologics portfolio is available through Premier Inc., effective June 1, according to a company press release. “The…
Feature Article

Sequential Harvesting of Bone Graft From the Intramedullary Canal of the Femur

Orthopedics, September/October 2014, Volume 37 Issue 9
The effectiveness of using the Reamer/Irrigator/Aspirator (RIA) System (Synthes, Inc, West Chester, Pennsylvania) to…
More »
CME

Bundled Payments in Orthopedic Surgery: February 2015

Bundled payments, the idea of paying a single price for a bundle of goods and services, is a financial concept familiar…
More »
Featured
EFORT Annual Congress

EFORT Annual Congress

Video
Meeting News Coverage

VIDEO: A perspective on stem cell implantation for osteonecrosis of the femoral head

January 30, 2014
More »
Industry NewsFrom OT Europe

BONESUPPORT announces IPO on Nasdaq Stockholm

June 18, 2017
BONESUPPORT announced its board of directors has applied for shares of the company to be admitted into trading on Nasdaq Stockholm’s main…

Point/Counter

What is the best current delivery method to ensure mesenchymal stem cells get to the intended target in the shoulder?

Orthopedics Today, June 2017
The best delivery method into the shoulder for mesenchymal stem cells (MSCs), PRP or other substances is based on the injection technique. The…

Cover Story

Controversy, cost may not dim potential of stem cells in the shoulder

Orthopedics Today, June 2017
It is widely known and reported in the literature that shoulder injuries, including rotator cuff tears, tend to heal slowly and the management of…

Bioventus announces expansion of surgical orthobiologics portfolio offering with Premier

June 10, 2017
Bioventus announced its full surgical orthobiologics portfolio is available through Premier Inc., effective June 1, according to a company press…

Meeting NewsFrom OT Europe

Researchers from Medical University of Graz receive EFORT/Medtronic Award

June 2, 2017
VIENNA — A team of researchers led by Sriveena Srinivasaiah, MSc, of the Department of Orthopaedic Surgery, Medical University of Graz, Graz…

Movers and Shakers

Lieberman receives NIH grant for research on gene therapy for repair of bone injuries

May 26, 2017
Jay R. Lieberman, MD, chair and professor of orthopedic surgery at Keck School of Medicine of the University of Southern California received a…

In the Journals

Greater number of mesenchymal stem cells released with fibrous synovium in culture model

May 15, 2017
Investigators of this study found fibrous synovium compared with adipose synovium release a greater number of mesenchymal stem cells in a suspended…

Meeting News

Etanercept seen as effective against bone marrow lesions in patients with hand OA

May 8, 2017
LAS VEGAS — Etanercept was effective for the inhibition of bone marrow lesions in patients with erosive hand osteoarthritis, according to a…

Meeting News

Etanercept linked with pain relief in prespecified per-protocol analysis of symptomatic hand OA

April 28, 2017
LAS VEGAS — Although investigators found non-superiority of etanercept compared with placebo overall in their study, they noted an analysis of…

Meeting News

Adalimumab did not provide significant relief of pain, synovitis in patients with hand OA

April 28, 2017
LAS VEGAS — Patients with erosive hand osteoarthritis treated with adalimumab experienced no significant alleviation of pain, synovitis or bone…

More Headlines »
Advertisement
Advertisement